ReviewFrontiers in cell and developmental biology2026
The palmitoylation code in cell death signaling: from molecular mechanisms to therapeutic opportunities.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Protein Palmitoylation as a Molecular Switch Linking Regulated Cell Death and Disease.Biomolecules · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The dynamic lipid modification known as protein palmitoylation is essential for modulating protein activity and subcellular distribution. This process is increasingly recognized as a pivotal molecular mechanism governing the balance between cellular survival and death. This paper explores the molecular regulation of palmitoylation within diverse pathways of regulated cell death, for instance, in necroptosis, ferroptosis, pyroptosis, and apoptosis. The core findings indicate that by controlling the stability, membrane anchoring, and interactions of key signaling proteins, palmitoylation can precisely regulate the ultimate fate of the cell. Additionally, the dysregulation of palmitoylation is closely linked to the pathogenesis of major human diseases, including cancer, neurodegenerative disorders, and inflammatory diseases. For instance, the process can display a dual role in tumor progression, acting to either promote or inhibit it. Concurrently, it is essential for the inflammatory signaling in pyroptosis and for mounting a cellular defense against ferroptosis. A deeper understanding of these regulatory networks provides highly promising therapeutic targets for disease intervention. Targeting the activity of specific palmitoylation-related enzymes has emerged as an innovative strategy for developing novel therapies for a range of diseases, demonstrating significant clinical translational potential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.